Franck Tirode
Tirode, Franck
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 313548424 ( Personal )
Permalink: http://viaf.org/viaf/313548424
Preferred Forms
-
100 0 _
‡a
Franck Tirode
-
100 1 _
‡a
Tirode, Franck
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| Abnormal vascularization of soft-tissue sarcomas on conventional MRI: Diagnostic and prognostic values |
|
| Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions |
|
| Analyse Intégrée génomique, protéomique et radiomique des Sarcomes Pléomorphes Indifférenciés : Identification et Validation de nouvelles cibles thérapeutiques |
|
| Antagonism pattern detection between microRNA and target expression in Ewing's sarcoma |
|
| BAFfling pathologies: Alterations of BAF complexes in cancer. |
|
| Bone sarcomas: from biology to targeted therapies. |
|
| Brain tumor with an ATXN1-NUTM1 fusion gene expands the histologic spectrum of NUTM1-rearranged neoplasia |
|
| Calpain-6 controls the fate of sarcoma stem cells by promoting autophagy and preventing senescence. |
|
| La calpaine- 6 identifie et maintient la population de cellules souches des necones osseux en contrôlant les processus d'autophagie et de sénescence. |
|
| Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage |
|
| [Cellular origin of Ewing's tumor. A corner of the veil is lifted]. |
|
| Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite |
|
| CIC-DUX4 expression drives the development of small round cell sarcoma in transgenic zebrafish: a new model revealing a role for ETV4 in CIC-mediated sarcomagenesis |
|
| Clear Cell Tumor With Melanocytic Differentiation and ACTIN-MITF Translocation: Report of 7 Cases of a Novel Entity |
|
| Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum |
|
| Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model |
|
| Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene |
|
| Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi institutional study of the International Mesothelioma Panel from MESOPATH Reference Center |
|
| A conditionally expressed third partner stabilizes or prevents the formation of a transcriptional activator in a three-hybrid system |
|
| Conséquences cellulaires de la formation de translocations chromosomiques : le modèle du lymphome anaplasique à grandes cellules (ALCL) |
|
| CRTC1-TRIM11 fusion defined melanocytic tumors: A series of four cases |
|
| Cutaneous Melanocytic Tumors With Concomitant NRASQ61R and IDH1R132C Mutations: A Report of 6 Cases |
|
| CYSLTR2-mutant Cutaneous Melanocytic Neoplasms Frequently Simulate "Pigmented Epithelioid Melanocytoma," Expanding the Morphologic Spectrum of Blue Tumors: A Clinicopathologic Study of 7 Cases |
|
| deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish |
|
| Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe |
|
| The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report |
|
| Epigenetic of Primary Bone Tumors' Progression and Chemoresistance. |
|
| ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion |
|
| ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions. |
|
| EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach |
|
| EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. |
|
| Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes |
|
| Genetic analyses of undifferentiated small round cell sarcoma identifies a novel sarcoma subtype with a recurrent CRTC1-SS18 gene fusion. |
|
| Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone |
|
| Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations |
|
| Identification et caractérisation de nouvelles anomalies moléculaires récurrentes dans les sarcomes |
|
| Inactivation and activation of chromosomal regions by epigenetic modifications.Mechanisms involved and role in tumor progression in bladder cancer.. |
|
| Integrative characterization of oncogenesis and immune response in sarcoma |
|
| Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee |
|
| Intra- and extra-cranial BCOR-ITD tumours are separate entities within the BCOR-rearranged family |
|
| Liquid Biopsy in Pediatric Sarcoma |
|
| Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma |
|
| Malignant melanoma with areas of rhabdomyosarcomatous differentiation arising in a giant congenital nevus with RAF1 gene fusion |
|
| Mécanismes épigénétiques associés à la progression et à la chimiorésistance des sarcomes osseux |
|
| Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations |
|
| Mesenchymal stem cell features of Ewing tumors |
|
| Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural History |
|
| Neonatal Soft Tissue Sarcoma with YWHAE-NUTM2B Fusion |
|
| A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. |
|
| New targeted approaches for the treatment of Ewing's sarcoma family of tumors. |
|
| NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker |
|
| Nouvelles approches ciblées pour le traitement des tumeurs de la famille du sarcome d'Ewing |
|
| Novel three-way complex rearrangement of TRPM1-PUM1-LCK in a case of agminated Spitz nevi arising in a giant congenital hyperpigmented macule |
|
| De novo motif identification improves the accuracy of predicting transcription factor binding sites in ChIP-Seq data analysis. |
|
| Oncogenèse et infiltrat immunitaire dans les sarcomes. |
|
| The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function |
|
| Oncostatin M is a growth factor for Ewing sarcoma. |
|
| The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors |
|
| Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL |
|
| PAX3-FOXO1 transgenic zebrafish models identify HES3 as a mediator of rhabdomyosarcoma tumorigenesis. |
|
| Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival. |
|
| RECONSTITUTION DU FACTEUR DE TRANSCRIPTION/REPARATION TFIIH ET RECHERCHE DE SES PROTEINES CIBLES |
|
| Reconstitution of the transcription factor TFIIH: assignment of functions for the three enzymatic subunits, XPB, XPD, and cdk7 |
|
| Recurrent novel THBS1-ADGRF5 gene fusion in a new tumor subtype "Acral FibroChondroMyxoid Tumors" |
|
| A Role for the TFIIH XPB DNA Helicase in Promoter Escape by RNA Polymerase II |
|
| The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease |
|
| SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses |
|
| SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas. |
|
| SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma |
|
| SRF Fusions Other Than With RELA Expand the Molecular Definition of SRF-fused Perivascular Tumors |
|
| [Stem cells and connective-tissue tumors: Ewing's sarcoma]. |
|
| Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas. |
|
| Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis |
|
| Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1. |
|
| Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growth. |
|
| Therapeutic targeting of cellular stress response in Osteosarcoma. |
|
| Tocilizumab for the treatment of paraneoplastic inflammatory syndrome associated with angiomatoid fibrous histiocytoma |
|
| Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution |
|
| Transcriptomic definition of molecular subgroups of small round cell sarcomas. |
|
| Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis. |
|
| Update on Families of Round Cell Sarcomas Other than Classical Ewing Sarcomas. |
|
| Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. |
|
| Very long-term survivors among patients with metastatic soft tissue sarcoma |
|
| Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients. |
|
